Dose-Ranging Study of the Bimatoprost Ocular Insert
Public ClinicalTrials.gov record NCT02358369. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Prospective, Multicenter, Randomized, Double-masked, Controlled Study to Evaluate the Efficacy and Safety and Dose-response of the Bimatoprost Ocular Insert (2.2 mg, 13 mg) With and Without Concomitant Artificial Tears Compared to a Placebo Ocular Insert With and Without Concomitant Timolol (0.5%) Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
Study identification
- NCT ID
- NCT02358369
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- ForSight Vision5, Inc.
- Industry
- Enrollment
- 156 participants
Conditions and interventions
Conditions
Interventions
- Bimatoprost Drug
- Timolol 0.5% Drug
- Placebo Ocular Insert Device
- Placebo Eye Drops Drug
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 18, 2015
- Primary completion
- Aug 30, 2015
- Completion
- Oct 6, 2015
- Last update posted
- Jun 3, 2020
2015
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vold Vision | Fayetteville | Arkansas | 72704 | — |
| Sall Medical Research Center | Artesia | California | 90701 | — |
| Eye Research Foundation | Newport Beach | California | 92663 | — |
| Clayton Eye Center | Morrow | Georgia | 30260 | — |
| Mundorf Eye Center | Charlotte | North Carolina | 28204 | — |
| Cornerstone Health Care | High Point | North Carolina | 27262 | — |
| Apex Eye | Madeira | Ohio | 45243 | — |
| University of Eye Specialists | Maryville | Tennessee | 37803 | — |
| Total Eye Care | Memphis | Tennessee | 38119 | — |
| R&R Eye Research, LLC | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02358369, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2020 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02358369 live on ClinicalTrials.gov.